Lors de l' IDWeek, la réunion annuelle de l' Infectious Diseases Society of America (IDSA), qui se tiendra à Boston, Massachusetts, Valneva organisera la table ronde « Chikungunya is an Increasing Global Threat : The Need for Better Protection » le 14 octobre 2023 à 18h00 Eastern Daylight Time (EDT).
Thomas Lingelbach, Chief Executive Officer of Valneva, will participate in 1on1 and small group investor meetings, as well as a roundtable discussion on “Prevention and early detection – Post-COVID perspectives for diagnostics, vaccines & therapeutics,” alongside Emma Walmsley, CEO of GSK; Thierry Bernard, CEO of Qiagen and Chair of AdvaMedDx; Mark Miller, EVP and Chief Medical Officer of bioMerieux; and Dr Jean-Paul Stahl, Head of the Department of Infectious Diseases; University Hospital, Grenoble (France) and former President of the French Infectious Diseases Society.
La Société sera disponible pour des réunions individuelles avec les investisseurs. Pour demander une réunion, veuillez contacter votre représentant Goldman Sachs.